Abiomed Inc.

33 clinical trials · Sponsor

Record	Firm	Date
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery (NCT06965504)	Abiomed Inc.	2026-04-01
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock (NCT06964685)	Abiomed Inc.	2025-07-10
Abiomed Impella RT-DAQ - Observational Study (NCT06308055)	Abiomed Inc.	2024-10-04
Impella RP Flex with Smart Assist (NCT06637644)	Abiomed Inc.	2024-05-29
The RECOVER IV Trial (NCT05506449)	Abiomed Inc.	2023-10-28
V-A ECMO AUTO Mode Registry (NCT05759377)	Abiomed Inc.	2023-10-11
IMpella-Protected cArdiaC Surgery Trial (IMPACT) (NCT05529654)	Abiomed Inc.	2023-09-21
IMPACT EU Post-Market Clinical Follow-Up Study (NCT05756751)	Abiomed Inc.	2023-04-27
Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol (NCT05334784)	Abiomed Inc.	2022-12-20
Impella Real-World Surveillance of Patients Using Sodium Bicarbonate (NCT05820451)	Abiomed Inc.	2022-12-15
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study (NCT05291884)	Abiomed Inc.	2022-04-20
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function (NCT04763200)	Abiomed Inc.	2021-04-13
Breethe Abiomed Recovery RegisTry (BART) (NCT05473130)	Abiomed Inc.	2021-03-31
The Smart Pump Study (NCT04465201)	Abiomed Inc.	2020-11-02
Impella ECP Early Feasibility Study (NCT04477603)	Abiomed Inc.	2020-10-09
SURPASS Impella 5.5 Study (NCT05100836)	Abiomed Inc.	2020-09-21
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial (NCT03947619)	Abiomed Inc.	2019-12-12
Restore EF Observational Study (NCT04648306)	Abiomed Inc.	2019-09-01
SVC Occlusion in Subjects With Acute Decompensated Heart Failure (NCT03836079)	Abiomed Inc.	2019-07-31

Track Abiomed Inc. automatically

Every clearance here is in the API, with alerts when new ones post.